PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Isik AT et al. – The study showed no relation between cognitive improvement and IR by galantamine therapy in AD. Peripheral IR and central nervous system IR may be different, and galantamine itself may show its effects without affecting the insulin–signaling pathway.

   

Related Articles

Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09    Relevance Score: 71%

High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09    Relevance Score: 70%

Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09    Relevance Score: 69%

The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09    Relevance Score: 68%

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09    Relevance Score: 68%

Today in Psychiatry...keeping you current

Development and psychometric evaluation of a new measure of pain-related support preferences: The Pain Response Preference Questionnaire
Pain Research and Management, 12/10/09

Integrated Group Therapy for a Heterogeneous Outpatient Sample
The Journal of Nervous and Mental Disease, 12/10/09

Cognitive impairment of executive function as a core symptom of schizophrenia
World Journal of Biological Psychiatry, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address